Recombinant human tumour necrosis factor beta (lymphotoxin) lacks chemotactic activity for human peripheral blood neutrophils, monocytes, and T cells

Scand J Immunol. 1989 Sep;30(3):373-7. doi: 10.1111/j.1365-3083.1989.tb01224.x.

Abstract

Human recombinant tumour necrosis factor beta (rhuTNF beta)/lymphotoxin was tested for human neutrophil granulocyte (PMN), monocytes (MO), and T-cell chemotactic activity by means of a modified Boyden chamber system. Over a wide range of concentrations (10(-7)-10(-14)M)rhuTNF beta showed no chemotactic activity for PMN, MO, or T cells. In contrast, strong chemotactic migration was elicited in PMN and MO with the tripeptide N-formyl-methionyl-leucyl-phenylalanine (FMLP) and in T cells when complement split product C5a and leukotriene B4 (LTB4) were used as chemotaxins. The results of this study indicate that rhuTNF beta/lymphotoxin is not a chemotaxin for human PMN, MO, or T lymphocytes in vitro.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chemotactic Factors / pharmacology*
  • Humans
  • In Vitro Techniques
  • Monocytes / drug effects*
  • N-Formylmethionine Leucyl-Phenylalanine / pharmacology
  • Neutrophils / drug effects*
  • Recombinant Proteins / pharmacology
  • T-Lymphocytes / drug effects*
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Chemotactic Factors
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • N-Formylmethionine Leucyl-Phenylalanine